Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.66% | 54.82% | 74.00% | 64.39% | 24.17% |
| Total Depreciation and Amortization | -80.43% | -85.87% | -88.41% | -67.21% | -44.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -199.67% | -107.50% | -127.33% | -133.83% | 236.91% |
| Change in Net Operating Assets | 495.75% | 575.25% | 178.56% | 115.03% | 123.00% |
| Cash from Operations | 36.49% | 57.72% | 76.73% | 71.26% | 61.79% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -398.84% | -294.23% | 204.85% | -102.62% | -102.46% |
| Cash from Investing | -457.68% | -314.95% | 191.23% | -102.39% | -102.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 66.31% | 72.25% | 45.03% | 19.41% | -32.24% |
| Issuance of Common Stock | 52,724.75% | 45,370.79% | 10,493.07% | 3,481.40% | -- |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 100.00% | -53.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 471.61% | 389.63% | 169.57% | 112.43% | -51.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.77% | 97.45% | 90.89% | 59.21% | 22.19% |